We report a case of severe tinea capitis, treated successfully with griseofulvin. In our opinion, the treatment ofthis severe dermatophytosis with griseofulvin is safe and effective. Other treatments, such as itraconazole pulsed therapy, failed, despite an initial improvement, leading to an aggressive recurrence of the lesion. We chose griseofulvin for its well-known large spectrum activity, also against uncommon species, like Microsporum Gypseum, which are responsible for the most severe cases.
Case report
We report the case of a 3-year-old male child (weight, 12 kg), resident in a rural area, who presented an erythematous scaly plaque associated with hair loss. The child had been previously subjected to a direct examination of the skin scrapings with potassium hydroxide (KOH) solution revealing fungal hyphae and, to a culture examination resulting positive for Microsporum gypseum. He therefore underwent systemic itraconazole 60 mg/day (5/mg/ kg/day) as pulsed therapy for seven days per cycle. After the first cycle he showed a clinical improvement, but after 2 additional cycles of treatment, there was an exacerbation of the pre-existing lesion in the vertex region. Thus, the patient underwent clinical observation; the lesion showed active inflammation and infection signs, consisting of a 5 em wide erythematous infiltrated plaque covered in pustules associated with hair loss and edematous skin ( Fig.  la) . We decided to perform a culture examination of the purulent material, confirming the presence of Microsporum gypseum (Fig. 2 
a-b).
Oral micronized griseofulvin 250 mg/day (20mg/ kg/day) was administered for 3 months, monitoring liver function and total blood count.
Although culture examination was still positive, there was a visible improvement within three weeks of therapy ( Fig. 1b ). After three months of therapy, the lesions completely disappeared. At a six-month follow-up, hair growth in the affected area was almost complete except for the scarring areas ( Fig.  1c ), and no recurrence has been observed to date.
DISCUSSION
The most frequent dermatophytes responsible for Microsporum gypseum, an ectothrix geophilic fungus, is uncommonly encountered as an etiologic agent of tinea capitis in humans. Griseofulvin is an old antibiotic derived from Penicillium griseofulvum, able to disrupt the formation of microtubules in the mitotic spindle, preventing fungus mitosis and its proliferation. The efficacy against various species ofdennatophytes and its well-known safety profile has made griseofulvin the standard treatment of scalp dermatophytoses since 1958. The introduction of new systemic antifungal agents questioned the "supremacy" of this drug. In fact, terbinafine, itraconazole and fluconazole replaced griseofulvin in the treatment of onychomycosis and recently, they have been found to be efficacious also in the treatment of tinea capitis (2) (3) (4) (5) . An emerging therapeutic approach is pulse treatment with itraconazole, consisting of lowdoses taken twice daily for one week per month, with the treatment repeated for two to three months (i.e., two to three "pulses"). Good responses have been demonstrated with this therapeutic administration (6, 7) . In addition, oral suspension of antifungal medications can be used to provide an easier dosing management in children (8) .
In our experience, treatment of dermatophytosis with griseofulvin is more effective than itraconazole pulse therapy. In the present case, in fact, the itraconazole pulse therapy, despite the initial improvement, led to an aggressive recurrence of the lesion. We chose griseofulvin for its well-known large spectrum activity, also against uncommon species, such as M gypseum, which are responsible for the most severe cases (2, 3, 9, 10) .
New antifungal agents, such as terbinafine, are more effective than griseofulvin in the treatment of tinea capitis supported by the most common dennatophytes, ego Trichophyton tonsurans. However, griseofulvin has been shown to be more effective than terbinafine in the infection caused by the Microsporum genus (3) . Griseofulvin accumulates itself in the keratin structures and when these become detached, due to the normal growth of the epidermis, they are slowly replaced by structures that contain a high amount of griseofulvin, giving reasons for a prolonged treatment (11). Recent studies have also described possible immune-modulator properties of griseofulvin, showing its role in the down-regulation of the expression of cell adhesion molecules on both leukocytes and vascular endothelial cells and blocking a crucial step in the inflammatory process (12) .
In children, maybe due to a peculiar immune system, and in pathological conditions (13) (14) (15) (16) (17) (18) , treatment of Microsporum infections of the scalp can be difficult, and long-standing tinea capitis may lead to severe scarring alopecia with great discomfort for the young patients and their parents. We present this case because M gypseum is an uncommon etiologic agent oftinea capitis and to highlight that griseofulvin remains the best therapeutic choice, especially in aggressive cases that are not well controlled with pulsed therapy.
